Dottikon reported a 30% fall in sales to CHF80.1m for the year ended 31 March 2011 compared to 2010 and a net loss of CHF7.1m compared to income of CHF12.6m the previous year. The company said the main contributor to the sales decline was a 37% fall in sales of pharmaceutical products as a result of several discontinued and delayed customer projects in the late development phase, together with persistent price and currency pressure.
Dottikon
Wednesday 8 June 2011
Sales fall at Dottikon
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment